|Articles|October 11, 2016

Zika Virus Skin Rash: Another Symptom of Infection?

A recent study details a case of a man with a confirmed Zika virus infection accompanied by papular descending eruption, petechiae on his palate, and hyperemic sclerae.

As clinicians continue to struggle with the differential diagnosis between Zika virus infection and two closely related diseases—Dengue virus and Chikungunya—new research out of the Hofstra/Northwell School of Medicine may provide them with a new diagnostic marker—a precise characterization of how it manifests on the skin.

In a case report published in June by the Journal of the American Medical Association—Dermatology, Amit Garg, MD and colleagues describe the case of a 44-year-old male who had travelled to Puerto Rico, where local transmission of Zika via Aedes aegypti mosquitos has been well documented, with confirmed infection. Dr. Garg et al noted that the patient had a diffuse papular descending eruption, petechiae on his palate, and hyperemic sclerae.

The authors could not be reached for comment. However, they noted in their concluding remarks that increased understanding of the mucocutaneous findings associated with Zika virus infection may assist clinicians in recognizing the disease and eliminating it from consideration when patients present with other more common erythematous eruptions. They wrote, “A detailed awareness of mucocutaneous findings associated with Zika virus infection will support its early recognition and will facilitate elimination of Zika infection from consideration for concerned patients who present with other, more common erythematous eruptions.”

A detailed awareness of mucocutaneous findings associated with Zika virus infection will support its early recognition and will facilitate elimination of Zika infection from consideration for concerned patients who present with other, more common erythematous eruptions.

Earlier research by clinicians in Brazil has established the most common signs or symptoms of Zika as: macular or maculopapular rash (97%), followed by pruritus (79%), prostration (73%), headache (66%), arthralgias (63%), myalgias (61%), nonpurulent conjunctivitis (56%), and lower back pain (51%).

Brian P. Dunleavy is a medical writer and editor based in New York. His work has appeared in numerous healthcare-related publications. He is the former editor of Infectious Disease Special Edition.


Related to this article

FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
Following World Rabies Day and a CDC health advisory on a 17% rise in exposure-related calls, Rodney E. Rohde, PhD, explains what the increase means, what people should do when they have an animal bite or scratch, and how clinicians should assess risk and administer post-exposure prophylaxis (PEP).
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.